Cerium-lanthanum treatment method for reduction of contaminants in wastewater membrane bioreactors
Disclosed are methods of treating wastewater using a membrane bioreactor and achieving a target phosphorus concentration for the membrane permeate stream. These methods include the steps of dosing a wastewater stream with a rare earth clarifying agent and passing the dosed wastewater stream through the membrane to obtain a membrane permeate stream with a permeate concentration that is less than the phosphorus concentration of the influent stream. This permeate concentration also can be equal to or less than a target phosphorus concentration. In the methods as disclosed herein, the rare earth clarifying agent can be chloride salts of one or more rare earth elements and in certain embodiments, the rare earth clarifying agent can be CeCl 3 and LaCl 3 .
1. A method for treating wastewater using a membrane bioreactor comprising:
dosing a wastewater stream, as part of a membrane bioreactor system, containing a first concentration of phosphorus with a dose amount of a rare earth clarifying agent to obtain a dosed wastewater stream, the first concentration of phosphorus being greater than a target concentration of phosphorus; and
passing the dosed wastewater stream through a membrane of the membrane bioreactor system to obtain a membrane permeate stream, the membrane permeate stream having a permeate concentration of phosphorus less than the first concentration phosphorus, wherein the membrane of the membrane bioreactor system is selected from the group consisting of polyvinylidene fluoride (PVDF); polyether sulfone (PES); polysulfone (PS); polyacrylonitrile (PAN); polyvinylchloride (PVC); polypropylene; chlorinated polyethylene; polyimide; polyamide; cellulose acetate; silicone-coated polyimide; polyether ether ketone (PEEK), alumina, silica, or ceramic.
2. The method of claim 1 , wherein the membrane is PES, PVDF, or PAN.
3. The method of claim 2 , wherein the rare earth clarifying agent comprises CeCl 3 and LaCl 3 .
4. The method of claim 1 , wherein the membrane pore size is approximately 0.0001 microns to 0.5 microns.
5. The method of claim 4 , wherein In certain embodiments, the membrane pore size is approximately 0.01 to 0.5 microns.
6. The method of claim 1 , wherein the membrane is a flat sheet, hollow fiber, tubular, or spiral wound.
7. The method of claim 1 wherein the rare earth clarifying agent comprises chloride salts of a mixture of rare earth elements.
8. The method of claim 1 , wherein the membrane permeate stream has a permeate concentration of phosphorus equal to or less than the target concentration of phosphorus.
9. The method of claim 1 , further comprising:
adjusting the dose amount of the clarifying agent based on the permeate concentration of phosphorus.
10. The method of claim 1 , further comprising:
increasing the dose amount of the clarifying agent if the permeate concentration of phosphorus is greater than the target concentration of phosphorus so that the permeate concentration of phosphorus is equal to or less than the target concentration of phosphorus.
11. The method of claim 1 , further comprising:
holding the dosed wastewater stream for a residence time before passing the dosed wastewater stream through the membrane.
12. The method of claim 1 , wherein the dose amount of the clarifying agent is from about 0.0005 to about 5.0 mmol RE/L wastewater.
13. The method of claim 1 , wherein the dose amount of the clarifying agent is from about 0.005 to about 1.0 mmol RE/L wastewater.
14. The method of claim 1 , wherein the dose amount of the clarifying agent is from about 0.01 to about 0.2 mmol RE/L wastewater.
15. The method of claim 1 , wherein the membrane bioreactor system is operated without fouling of the membrane from 25 to 75% longer than operation of a membrane bioreactor using a ferric clarifying agent.
16. The method of claim 15 , wherein the membrane bioreactor system is operated without fouling of the membrane from 35 to 70% longer than operation of a membrane bioreactor using a ferric clarifying agent.
17. The method of claim 16 , wherein the membrane bioreactor system is operated without fouling of the membrane from 45 to 65% longer than operation of a membrane bioreactor using a ferric clarifying agent.
18. The method of claim 1 , wherein the target concentration of phosphorus is a limit of 0.05 mg/L to 1.0 mg/L.
19. A method for treating wastewater using a membrane bioreactor comprising:
dosing a wastewater stream, as part of a membrane bioreactor system, containing a first concentration of phosphorus with a dose amount of a rare earth clarifying agent comprising CeCl 3 and LaCl 3 to obtain a dosed wastewater stream, the first concentration of phosphorus being greater than a target concentration of phosphorus;
removing at least some of the phosphorus as precipitated sludge from the wastewater stream; and
passing the dosed wastewater stream through a membrane of the membrane bioreactor system to obtain a membrane permeate stream, the membrane permeate stream having a permeate concentration of phosphorus less than the first concentration phosphorus, wherein the membrane of the membrane bioreactor system is selected from the group consisting of polyvinylidene fluoride (PVDF); polyether sulfone (PES); polysulfone (PS); polyacrylonitrile (PAN); polyvinylchloride (PVC); polypropylene; chlorinated polyethylene; polyimide; polyamide; cellulose acetate; silicone-coated polyimide; polyether ether ketone (PEEK), alumina, silica, or ceramic.
20. The method of claim 19 , wherein the membrane is PES, PVDF, or PAN.